AstraZeneca PLC (NYSE:AZN) was among the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the ...

Is AZN a good stock to buy? We came across a bullish thesis on AstraZeneca PLC on South Sea Investing’s Substack. In this article, we will summarize the bulls’ thesis on AZN. AstraZeneca PLC’s share ...

AstraZeneca (AZN) climbed 3.1% as Bernstein reaffirms outperform rating, citing non-oncology portfolio as undervalued driver ...

Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter AstraZeneca ( (GB:AZN)) has shared an update. AstraZeneca has confirmed that as of 31 ...

AstraZeneca AZN stock has risen 15% so far this year compared with an increase of 0.2% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AstraZeneca’s experimental GLP-1 pill cut body weight by nearly 12% in obese patients over 36 weeks and reduced A1C, a metric ...